SEC Tracker
Get the app

Veracyte VCYT

Stapley Marc (Director) plans to sell 45,523 VCYT shares, about $1.6M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Mar 4, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Performance Stock Units; Restricted Stock Units
  4. 10b5-1 plan adopted: Nov 24, 2025

All of Stapley Marc's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 19,244 shares at $35.56 on Mar 4, 2026 · Form 4
  • Sold 26,279 shares at $36.28 on Mar 4, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Veracyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. GRAIL GRAL public float $1.9B, Jun 30, 2025
  2. BillionToOne BLLN
  3. CareDx CDNA public float $1.0B, Jun 30, 2025
  4. Lumexa Imaging Holdings LMRI
  5. Caris Life Sciences CAI public float $3.9B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.